Sriram Shamungum, Aiswaria Varghese, Cijo Annie Eapen, Mohankumar Thekkinkattil
Department of Pharmacy Practice, College of Pharmacy, SRIPMS, Coimbatore, Tamil Nadu, India.
Department of Pulmonology, Sri Ramakrishna Hospital, Coimbatore, Tamil Nadu, India.
J Res Pharm Pract. 2013 Apr;2(2):70-4. doi: 10.4103/2279-042X.117386.
The purpose of this study is to analyze the antibiotic sensitivity pattern of microorganisms, to study the antibiotic usage pattern, and to conduct a cost-effectiveness analysis (CEA) for the antibiotics prescribed in a tertiary care teaching hospital in south India.
This prospective study was carried out in the General Medicine and Pulmonology departments of the hospital for a period of 6 months. The study was carried out in three phases: A prospective analysis to check the sensitivity pattern of microorganisms to various antibiotics, data extraction and determining the cost of antibiotics and finally evaluation of the sensitivity pattern of microorganisms and the antibiotic usage. A total of 796 documented records were analyzed.
It was found that Escherichia coli was the major organism identified in 36.4% of the isolated specimens, followed by Klebsiella sp. (18.9%), Streptococcus pneumoniae (15.8%), Staphylococcus aureus (12.4%), and Pseudomonas (9.3%). The sensitivity pattern data of the prospective study revealed that E. coli was highly sensitive to Amikacin (99.3%), Klebsiella to Amikacin (93.8%), Pseudomonas to Meropenem (97.6%), and S. pneumoniae to Ofloxacin (93.8%). In the prescribing pattern study, it was found that the most common disease (21.2%) was found to be lower respiratory tract infection in 51 patients. Cephalosporins (73%), in particular Ceftriaxone (63.5%) was highly prescribed, followed by fluoroquinolones (53.9%). In the CEA, it was revealed that Ceftriaxone was the cost-effective antibiotic with a cost-effectiveness ratio (CER) of 78.27 compared to Levofloxacin, which had a CER of 95.13.
Continuous surveillance of susceptibility testing is necessary for cost-effective customization of empiric antibiotic therapy. Furthermore, reliable statistics on antibiotic resistance and policies should be made available.
本研究旨在分析微生物的抗生素敏感性模式,研究抗生素使用模式,并对印度南部一家三级护理教学医院所开抗生素进行成本效益分析(CEA)。
本前瞻性研究在该医院的普通内科和肺病科进行,为期6个月。该研究分三个阶段进行:前瞻性分析以检查微生物对各种抗生素的敏感性模式,数据提取并确定抗生素成本,最后评估微生物的敏感性模式和抗生素使用情况。共分析了796份记录文件。
发现大肠杆菌是在36.4%的分离标本中鉴定出的主要微生物,其次是克雷伯菌属(18.9%)、肺炎链球菌(15.8%)、金黄色葡萄球菌(12.4%)和铜绿假单胞菌(9.3%)。前瞻性研究的敏感性模式数据显示,大肠杆菌对阿米卡星高度敏感(99.3%),克雷伯菌对阿米卡星敏感(93.8%),铜绿假单胞菌对美罗培南敏感(97.6%),肺炎链球菌对氧氟沙星敏感(93.8%)。在处方模式研究中,发现最常见的疾病(21.2%)是51例患者的下呼吸道感染。头孢菌素(73%),特别是头孢曲松(63.5%)的处方量很高,其次是氟喹诺酮类(53.9%)。在成本效益分析中,结果显示头孢曲松是具有成本效益的抗生素,成本效益比(CER)为78.27,而左氧氟沙星的成本效益比为95.13。
持续监测药敏试验对于经验性抗生素治疗的成本效益定制是必要的。此外,应提供关于抗生素耐药性的可靠统计数据和政策。